Observation Study of the Clinical Management of Bipolar Disorder

AstraZeneca520 enrolled

Overview

The objective of the ambispective cohort study is to describe clinical management and clinical outcomes related to bipolar disorder in China, and establish the factors associated with different management patterns and clinical outcomes, provide psychiatrists with reliable and up-to-date information on the disease.

Study Type

OBSERVATIONAL

Enrollment

520

Conditions

Bipolar Disorder

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Provision of subject informed consent. * Diagnosis of Bipolar Disorder I or II (DSM-IV TR) in any phase of the disorder. * Patients who had at least one mood event( depression, mania, hypomania or mixed) according to DSM-IV TR definition during the 3 and 12 months prior to the beginning of the study. Exclusion Criteria: * Inability to complete Patient Reported Outcomes (PROs) questionnaires. * Participation in an interventional clinical study in last 12 months.

Locations (6)

Research Site

Beijing, Beijing Municipality, China

Research Site

Shenzhen, Guangdong, China

Reserach Site

Shanghai, Shanghai Municipality, China

Research Site

Xi’an, Shanxi, China

Outcomes

Primary Outcomes

Number of episodes (depression, mania, hypomania or mixed).

Time frame: Up to 21 months

Secondary Outcomes

Treatments received for Bipolar Disorder: medication time.

Time frame: Up to 21 months

Treatments received for Bipolar Disorder: medication classes.

Time frame: Up to 21 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.